BioMarin也迅速跟进迭代研发，其升级版在研产品BMN333同样旨在实现周剂注射。早期临床结果显示BMN333的AUC水平高于其他长效CNP研究的3倍以上，公司研发主管Greg Friberg表示该药对标的正是TransCon-CNP。
The idea is to catch cancer before someone starts to get ill and when it can still be treated.
，这一点在同城约会中也有详细论述
if (chunks === null) {。heLLoword翻译官方下载是该领域的重要参考
He said: "What an absolute treat for Radio 2 in the Park to land in Scotland this summer.